These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 16391833

  • 1. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
    [Abstract] [Full Text] [Related]

  • 2. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T, Takai N, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [Abstract] [Full Text] [Related]

  • 3. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2008 Jan; 21(1):109-15. PubMed ID: 18097623
    [Abstract] [Full Text] [Related]

  • 4. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Matsuda K, Kusumoto M, Narahara H.
    Oncology; 2006 Jan; 70(2):97-105. PubMed ID: 16601366
    [Abstract] [Full Text] [Related]

  • 5. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
    [Abstract] [Full Text] [Related]

  • 6. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156
    [Abstract] [Full Text] [Related]

  • 7. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY, Jung JH, Na YJ, Kim HS.
    Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
    [Abstract] [Full Text] [Related]

  • 8. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Oncol Rep; 2008 Mar; 19(3):749-53. PubMed ID: 18288411
    [Abstract] [Full Text] [Related]

  • 9. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
    Takai N, Kawamata N, Gui D, Said JW, Miyakawa I, Koeffler HP.
    Cancer; 2004 Dec 15; 101(12):2760-70. PubMed ID: 15536623
    [Abstract] [Full Text] [Related]

  • 10. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
    Takai N, Ueda T, Kawano Y, Nishida M, Nasu K, Narahara H.
    Oncol Rep; 2005 Nov 15; 14(5):1287-91. PubMed ID: 16211298
    [Abstract] [Full Text] [Related]

  • 11. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.
    Takai N, Narahara H.
    Curr Med Chem; 2007 Nov 15; 14(24):2548-53. PubMed ID: 17979707
    [Abstract] [Full Text] [Related]

  • 12. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Anticancer Res; 2006 Nov 15; 26(2A):939-45. PubMed ID: 16619490
    [Abstract] [Full Text] [Related]

  • 13. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Gynecol Oncol; 2008 Apr 15; 109(1):107-14. PubMed ID: 18234298
    [Abstract] [Full Text] [Related]

  • 14. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nasu K, Narahara H.
    Gynecol Oncol; 2008 Nov 15; 111(2):336-43. PubMed ID: 18790523
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells.
    Lee EJ, Lee BB, Kim SJ, Park YD, Park J, Kim DH.
    Int J Oncol; 2008 Oct 15; 33(4):767-76. PubMed ID: 18813790
    [Abstract] [Full Text] [Related]

  • 16. K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1.
    Takai N, Ueda T, Nishida M, Nasu K, Fukuda J, Miyakawa I.
    Oncol Rep; 2005 Jul 15; 14(1):141-3. PubMed ID: 15944781
    [Abstract] [Full Text] [Related]

  • 17. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O.
    Eur J Haematol; 2006 Jan 15; 76(1):42-50. PubMed ID: 16343270
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
    Ahn MY, Lee J, Na YJ, Choi WS, Lee BM, Kang KW, Kim HS.
    Chem Biol Interact; 2009 May 15; 179(2-3):169-77. PubMed ID: 19070610
    [Abstract] [Full Text] [Related]

  • 19. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
    Wetzel M, Premkumar DR, Arnold B, Pollack IF.
    J Neurosurg; 2005 Dec 15; 103(6 Suppl):549-56. PubMed ID: 16383255
    [Abstract] [Full Text] [Related]

  • 20. A novel delta-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells.
    Kang MR, Kang JS, Han SB, Kim JH, Kim DM, Lee K, Lee CW, Lee KH, Lee CH, Han G, Kang JS, Kim HM, Park SK.
    Biochem Pharmacol; 2009 Sep 01; 78(5):486-94. PubMed ID: 19445901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.